How would you describe the impact of the prostate cancer registry on both basic and clinical research?

So a registry that is focused on African American men could have a very large impact on basic research and outcomes for African American men. And the reason is that there have been very few studies and the studies that exist generally consist of few African American participants. They compare that to a larger group of Caucasian patients or single studies where they only have less than a hundred or a hundred African American men. Suppose we could do research with thousands of African American men, we could really explore the biology, we could look at treatment outcomes and differences, and we could really describe the patient experience for African American men. And that's what we need, because they are at increased risk for the disease and dying from the disease.